CQENS Technologies Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019623 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$3.379M	$350.6K	$350.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses	$329.6K	$336.2K	$43.89K
Receivables
Other Receivables
Total Short-Term Assets	$3.709M	$686.8K	$394.5K
YoY Change	779.06%	242.68%	-2.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$147.5K	$152.5K	$157.6K
YoY Change	-12.02%	-11.67%	-11.34%
Goodwill
YoY Change
Intangibles	$1.212M	$1.181M	$1.144M
YoY Change	18.04%	17.03%	17.48%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.945M	$1.932M	$1.888M
YoY Change	9.74%	9.35%	7.85%
TOTAL ASSETS
Total Short-Term Assets	$3.709M	$686.8K	$394.5K
Total Long-Term Assets	$1.945M	$1.932M	$1.888M
Total Assets	$5.654M	$2.619M	$2.283M
YoY Change	157.65%	33.12%	6.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$144.1K	$208.0K	$104.2K
YoY Change	6.16%	59.53%	-53.19%
Accrued Expenses	$410.9K	$370.8K	$248.4K
YoY Change	37.09%	100.74%	164.16%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.866M	$1.896M	$1.316M
YoY Change	33.93%	130.61%	256.88%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.866M	$1.896M	$1.316M
Total Long-Term Liabilities
Total Liabilities	$1.866M	$1.900M	$1.337M
YoY Change	29.25%	116.31%	201.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.75M	-$24.85M	-$23.86M
YoY Change	17.91%	19.82%	22.0%
Common Stock	$2.639K	$2.620K	$2.618K
YoY Change	1.15%	0.46%	0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.788M	$718.3K	$946.0K
YoY Change
Total Liabilities & Shareholders Equity	$5.654M	$2.619M	$2.283M
YoY Change	157.65%	33.12%	6.01%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent		usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q1	CQENS	Increase Decrease In Prepaid Expenses Noncurrent Portion IncreaseDecreaseInPrepaidExpensesNoncurrentPortion		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2024Q1	CQENS	Lessee Operating Lease Liability Payments Due After Year One LesseeOperatingLeaseLiabilityPaymentsDueAfterYearOne		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	288829	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	390432	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	337072	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	316657	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	161351	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	995918	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1182946	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-995918	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1182946	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	153	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3361	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-995765	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1186307	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1132	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-994633	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1186307	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26184670	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26184670	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26069645	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26069645	shares
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	34	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-995799	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1186307	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-17	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-995782	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1186307	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	945966	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	205102	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	313000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	250000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	-34	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-995765	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	718269	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1710411	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1710411	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	384441	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	180000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1186307	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1088545	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1088545	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-995765	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1186307	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	29137	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	23729	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	14541	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	12799	usd
CY2024Q1	us-gaap	Depreciation Depreciation	5037	usd
CY2023Q1	us-gaap	Depreciation Depreciation	5037	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	205102	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	384441	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	250000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	292305	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-80612	usd
CY2024Q1	CQENS	Increase Decrease In Prepaid Expenses Noncurrent Portion IncreaseDecreaseInPrepaidExpensesNoncurrentPortion	27845	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	103791	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-92174	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-250000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14541	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-12799	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	122401	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	90686	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350447	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-693976	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	64504	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	57484	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64504	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57484	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	313000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	180000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	102037	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	450000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	415037	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	630000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-34	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	52	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-121460	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	350565	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	219781	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	350617	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	98321	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1400	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	28000	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	14250	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	285000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	7500	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	150000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1500	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	30000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	205102	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	384441	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26202670	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26202670	shares
CY2023Q2	CQENS	Increase In Rent IncreaseInRent	375	usd
CY2023Q2	CQENS	Lease Monthly Installments LeaseMonthlyInstallments	5175	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	62100	usd
CY2024Q2	CQENS	Increase In Rent IncreaseInRent	80	usd
CY2024Q2	CQENS	Lease Monthly Installments LeaseMonthlyInstallments	5255	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	63060	usd
CY2024Q1	CQENS	Leasehold Improvements Net LeaseholdImprovementsNet	6799	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65259	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	61228	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4031	usd
CY2024Q1	CQENS	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	14541	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y29D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	46575	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	20700	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	67275	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2016	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	65259	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	61228	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4031	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	498408	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	498408	usd
CY2023Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1046878	usd
CY2024Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1046878	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	526253	usd

Files In Submission

Name	View Source	Status
0001493152-24-019623-index-headers.html	Edgar Link	pending
0001493152-24-019623-index.html	Edgar Link	pending
0001493152-24-019623.txt	Edgar Link	pending
0001493152-24-019623-xbrl.zip	Edgar Link	pending
cqens-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cqens-20240331_lab.xml	Edgar Link	unprocessable
cqens-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
cqens-20240331_cal.xml	Edgar Link	unprocessable
cqens-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

CQENS Technologies Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224019623 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission